RNF19B

Across TCGA pan-cancer cohorts, RNF19B mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated RNF19B data layer compared with 23 for mass-spec protein and 4 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher RNF19B mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated RNF19B expression acts as an unfavorable survival marker.

HNSC and LSCC are the cancer types where RNF19B mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Tertile	All	0.595	0.866	.025	4	view →
LSCC	DFS	Median	III,IV	0.291	0.683	.034	4	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

RNF19B–HNSC (OS)

Open the HNSC breakdown →